Metals used in the oral cavity have been reported to cause various allergic diseases of the skin and mucosa. Skin manifestations due to dental restorations appear not only in the oral cavity, but also on the hands, feet or the whole body, as in the cases of pustulosis palmoplantaris and lichen planus. These phenomena implicate different pathogeneses from that of conventional skin sensitization and tolerance. Therefore, we compared skin and oral mucosa sensitization with nickel and oral tolerance for nickel in a mouse model. Female C57BL/6J mice were sensitized by injection of NiSO 4 into the skin or oral mucosa. Allergic reactions were evaluated by the mouse ear swelling test and splenocyte proliferation and cytokine profiles. Skin and oral mucosa sensitization succeeded in all mice. Ear swelling was significantly greater in the skin-than in the oral mucosa-sensitized mice at 48 hr after challenge. Ear swelling was also suppressed by single oral administration of NiSO 4 in both the skin-and oral mucosa-sensitized mice to the level of that in nonsensitized mice. Splenocytes from skin-sensitized mice proliferated similarly to those from oral mucosa-sensitized mice. Splenocytes from orally-tolerized mice also showed similar proliferation activity to those from skin and oral mucosa-sensitized mice. In the challenge phase, IL-2, IFN-␥, and IL-10 production was induced in splenocytes from both skin-and oral mucosa-sensitized mice. However, IL-4 was induced only in those from skin-sensitized mice. In addition, IL-4 in splenocytes from oral mucosa-sensitized mice was up-regulated to the level in those from skin-sensitized mice by oral tolerance. These results suggest that sensitization sites in mice influence not only the degree of excitation, but also Th-1 and Th-2 balance in the challenge phase and oral tolerance.
Introduction
Allergic contact dermatitis is known to be caused by nickel contained in metal accessories 8) . Nickel contained in dental materials in the oral cavity has been reported to cause various allergic disorders of the skin and mucosa 4) . Allergies such as conventional contact stomatitis occur in the oral mucosa near dental materials. However, dyshidrotic eczema appears in areas of skin distant from the contact site with dental materials 22) . This type of systemic allergic contact dermatitis is thought to be accompanied by systemic effects 7) . In contrast, patients who had oral contact with nickel-releasing orthodontic appliances when orthodontic treatment preceded ear piercing showed a reduced frequency of nickel hypersensitivity 18) . We believe that this may be explained by induction of oral tolerance through release of nickel ions.
Studies using peripheral blood mononuclear cells (PBMC) revealed that not only Th-1, but also Th-2 cytokines played an important role in sensitization and challenge with nickel 10) . Studies have also shown participation of IL-10 in tolerance for nickel 11) . However, digestive organs other than the oral mucosa are involved in sensitization and challenge by and oral tolerance to dentistry materials. Various clinical manifestations due to dental alloys other than skin sensitization implicate different pathogeneses from that of conventional skin sensitization and tolerance. As in the case of atopic and contact dermatitis, differences in Th-1 and Th-2 balance may be involved in these clinical variations 20) . In order to test this hypothesis, we need to compare skin and oral mucosa sensitization with nickel and oral tolerance for nickel in various models. Previous studies have shown that delayed-type hypersensitivity is induced in the oral mucosa by haptens such as 1-chloro-2, 4-dinitrobenzene (DNCB) 13) . However, a model for oral sensitization by metal ions such as those of nickel remains to be established.
There have been reports that mice splenocytes from sensitized donors can transfer nickel sensitization and that those from orally-tolerized donors can transfer nickel tolerance 2, 9, 16) . These results suggest that the spleen plays an important role in sensitization and orally-induced immunologic tolerance.
Therefore, we established skin-sensitized, oral mucosa-sensitized, and orally-tolerized mice by NiSO 4 . We then compared challenge reactions, splenocyte proliferation, and splenocyte cytokine profiles between these mice.
Materials and Methods

Animals
A total of 42 animals were used in total, divided into 7 groups of 6 animals each. Ten-week-old, female, inbred, C57BL/6J mice were purchased from CLEA Japan Inc. (Tokyo, Japan). Animal experiments were performed according to The Guidelines for the Treatment of Experimental Animals at Tokyo Dental College.
Antigen
We used 1M NiSO 4 (Wako Pure Chemicals Inc., Osaka, Japan) in 0.9% NaCl (Otsuka Pharmaceutical, Tokushima, Japan) mixed 1:1 with Complete Freund's Adjuvant (CFA), (Difco Laboratory, Detroit, MI).
Oral mucosa and skin sensitization
We performed oral mucosa and skin sensitization experiments with C57BL/6J mice using an adjuvant-based method. The administration sites were both flanks or the bilateral buccal mucosa. The mice were divided into groups of 6 for sensitization. In the skinsensitized mice, flank hair was shaved using electric hair clippers on the day before initiation of the test. On the day of initiation (Day 0), the mice were injected intradermally in both flanks with 50l solution containing 1M NiSO 4 in saline mixed 1:1 with CFA for sensitization 3) . Eleven days later, the mice were challenged by injection with 0.2M NiSO 4 in 20l saline into the pinna of each ear 19) . Ear thickness was measured at 24, 48, 72, and 96 hr after challenge using a digimatic thickness gauge Kanagawa, Japan). The difference in ear thickness between before and after challenge was presented as the mean (10 ‫2מ‬ mm)‫ע‬SD of ear swelling. Allergic reactions were evaluated with the mouse ear swelling test (MEST) 19) . In the oral mucosa-sensitized mice, 50l of 1mol NiSO 4 was injected submucosally in the bilateral buccal regions for sensitization on Day 0. As in the skin-sensitized mice, a reaction was induced 11 days after sensitization. The evaluation was the same as in the skin-sensitized mice. The experimental design is shown in Fig. 1 .
In the control mice, 50l CFA was injected into both flanks or the bilateral buccal regions on Day 0. As in the skin-and oral-sensitized mice, a reaction was induced 11 days after sensitization.
Single oral administration
For oral tolerance, mice were fed 50l of 1M NiSO 4 once before sensitization, while avoiding contact with the oral mucosa by use of a pipette. After a treatment-free interval of 2 weeks, the mice were sensitized at skin-or oral-mucosal sites. The orally-tolerized mice were divided into groups of 6 animals each. The experimental design is shown in Fig. 1 .
Preparation of splenocytes
All mice were sacrificed at 48 hr after challenge. The spleen was excised from all mice. A splenocyte suspension in phosphatebuffered saline (PBS) was prepared by crushing the spleen with a frosted glass slide. The suspension was filtered through a nylon mesh and centrifuged at 1,500 rpm for 5 min. After removal of the supernatant, a hemolysis solution (0.83% NH 4 Cl: Tris HCl, pH 7.4, 9:1v/v) was added to hemolyze red blood cells. The cells were filtered through a nylon mesh, washed twice with RPMI1640 ® (Lonza Walkersville, MD, USA) and a splenocyte suspension at ‫01ן5‬ 6 cells/ml prepared 14) .
1) Splenocyte proliferation
Splenocyte suspension was distributed onto a 96-well microplate at 200l/well. The splenocytes were then cultured at 37°C for 72 hr in a 5% CO 2 incubator. Finally, Eleven days later, they were challenged for recall at ears, and ear-swelling response as an indicator of nickel-allergic reaction determined. B: Naive mice were tolerized by single oral administration of 1M NiSO 4 . After treatment-free interval of 2 weeks, mice were sensitized in both flanks or bilateral oral mucosa. Eleven days later, mice were challenged for recall at ears. Ear-swelling was determined after excitation.
harvester and liquid scintillation counter. The experimental design is shown in Fig. 2 .
2) ELISA Splenocytes were cultured at 37°C for 72 hr in a 5% CO 2 incubator. The culture supernatants were sorted at ‫°02מ‬C prior to ELISA. In the culture supernatants, IL-2, IFN-␥, IL-4, and IL-10 were measured using a commercially available ELISA kit (R&D systems, Minneapolis, MN, USA). The experimental design is shown in Fig. 2 .
The lowest detection limit in ELISA was 7.8 pg/ml.
Statistical analysis
Statistical significance was determined with an ANOVA followed by the Mann-Whitney U-test. The level of significance was set at pϽ0.05.
Results
Time course of ear swelling after challenge by skin and oral mucosal sensitization
Ear swelling peaked in all mice at 48 hr after challenge. Ear swelling was significantly greater in both skin-and oral mucosasensitized mice than in non-sensitized mice (*: pϽ0.01, **: pϽ0.001, Fig. 3 ; pϽ0.001, Fig. 4, respectively) . Sensitization via the skin and oral mucosa was successful in all mice. Ear swelling was significantly greater in skinthan in oral mucosa-sensitized mice at 48 hr after challenge (pϽ0.01, Table. 1).
Time course of ear swelling after challenge
by single oral administration Ear swelling was significantly suppressed by single oral administration of NiSO 4 in both H-thymidine uptake was measured using cell harvester and liquid scintillation counter. B: ELISA Splenocytes were then cultured at 37°C for 72 hr in 5% CO 2 incubator. Culture supernatants were sorted at ‫°02מ‬C prior to ELISA. In culture supernatants, IL-2, IFN-␥, IL-4, and IL-10 were measured using commercially available ELISA kit (R&D systems, Minneapolis, MN, USA).
skin-and oral mucosa-sensitized mice to the level in control mice (Figs. 5 and 6 ).
Proliferation activity of splenocytes
The proliferation activity of splenocytes from all sensitized mice with or without single oral administration was significantly higher than that in untreated mice (*: pϽ0.05, **: pϽ0.001, respectively, Fig. 7 ). No significant difference was noted between the sensitized (Fig. 7) .
IL-2, IFN-␥, IL-4, and IL-10 production in cultured splenocytes
IL-2, IFN-␥, and IL-10 production was significantly increased in skin-and oral mucosasensitized mice and orally-tolerized mice compared with in untreated mice (pϽ0.01, Fig. 8, 11 ; *: pϽ0.05, **: pϽ0.001, Fig. 9 , respectively). However, IL-4 production was induced in skin-sensitized mice and orallytolerized mice (Fig. 10) .
No difference was noted in IL-2, IFN-␥, or IL-10 production with single oral administration between skin-and oral mucosa-sensitized mice (Fig. 8, 9, 11) .
IL-4 production in skin-sensitized mice was significantly higher than that in oral mucosasensitized mice (pϽ0.01, Fig. 10 ). IL-4 pro- duction in oral mucosa-sensitized mice was also significantly increased to the level of that in skin-sensitized mice by single oral administration (pϽ0.01, Fig. 10 ). However, no change was observed in IL-4 level by single oral administration in cutaneously sensitized mice.
Discussion
It has been reported that mice can be sensitized by percutaneous injection with NiSO 4 3) . However, there have been no previous reports on sensitization with NiSO 4 via the oral mucosa. In our study, all animals were sensitized either by percutaneous or submucosal administration. These results clearly indicate that NiSO 4 can sensitize via the oral mucosa similarly to other antigens such as DNCB 13) , although submucosal injection of an antigen does not completely simulate contact with dental materials as seen in a clinical setting. Furthermore, ear swelling was significantly greater in the skin-than in the oral mucosa-sensitized mice at 48 hr after challenge with NiSO 4 . Weaker swelling in the oral-sensitization mice may be due to the lower number of Langerhans' cells, as in the case of DNCB 13) . In previous reports, oral tolerance was successfully induced in mice by drinking water containing 9M NiSO 4 for 1 week or 10 mM NiCl 2 for 4 weeks 12, 15, 19) . We found that immunologic tolerance to nickel could only be induced by single oral administration.
A total of 1.1 mM nickel was taken up by mice drinking 10 mM NiCl 2 -containing water over 4 weeks in a previous report 12, 15) . In our experiment, only a total of 1M nickel induced tolerance by single oral administration, indicating that oral tolerance to nickel can be achieved at a lower concentration than suggested in earlier reports 12, 15, 19) . In a sensitization study using painting with picryl chloride, ear swelling was suppressed by single oral administration in skin-sensitized mice 1) . However, it was not suppressed in oral mucosa-sensitized mice 1) . In this study, using NiSO 4 , ear swelling was suppressed by single oral administration in both skin-and oral mucosa-sensitized mice. These discrepancies might to be related to differences in antigen and/or administration method.
Splenocyte proliferation was observed not only in NiSO 4 -sensitized mice, but also in orally-tolerized mice. We suspect that effecter Th-1 cells, Th-2 cells, Th-3 cells, or CD4
‫ם‬
CD25
‫ם‬ regulatory T cells proliferate in the spleen of NiSO 4 -sensitized and orally tolerized mice 6, 10, 11, 21) . We believe that the splenocyte proliferation seen in this study may reflect oral tolerance, as well as sensitization.
IL-2, IFN-␥, IL-4, and IL-10 production was increased in splenocytes from skin-sensitized mice. Nickel induces in vitro production of both Th1-and Th2-type cytokines in PBMC from allergic subjects 10, 11) . As in human, a mixed Th-1, Th-2-type cytokine response may occur in the splenocytes of the skin in mice sensitized with NiSO 4 . Ear swelling was reported to be suppressed by administration of anti-IL-4 antibody in mice sensitized with trinitrochlorobenzene via the skin. IL-4 is considered to be essential for ear swelling in skin-sensitized mice 17) . Our report supports this hypothesis. With oral mucosa sensitization, we showed ear swelling without increase in the IL-4 production of splenocytes. Previous studies 5, 17) have shown the essential role of IL-4 among hapten-specific T cell lines from lymph node cells in passive transfer to recipient mice. We believe that this discrepancy with the current results may be due to the investigation of different organs, sensitization with different haptens, or sensitization at different sites. Further study is necessary, however, to elucidate this point.
IL-2, IFN-␥, and IL-10, but not IL-4, production by splenocytes was increased in oral mucosa-sensitized mice. These results suggest that the reaction was Th-1-dominant. IL-2 production was slightly higher than that in skin-sensitized mice. On the other hand, IL-4 was significantly lower than in skin-sensitized mice. These results suggest that IL-4 production in splenocytes is affected by sensitization site.
By inducing oral tolerance, IFN-␥ production was slightly reduced only in skin-sensitized mice. This may indicate inhibition of Th-1 response by oral tolerance. In oral mucosasensitized mice, IL-4 production was significantly increased to the same level as that in skin-sensitized mice when oral tolerance was induced, indicating a mixed Th-1 and Th-2 response. Oral tolerance was reported to be accompanied by upregulation of IL-4 production in orally tolerized mice 6) . Therefore, these changes in cytokine production are considered to be associated with orally-induced immunologic tolerance. These results on challenge and oral tolerance suggest that Th-1 and Th-2 balance can also be influenced by sensitization site.
In conclusion, this MEST-based study demonstrated that mice can be sensitized with NiSO 4 via the oral mucosa, as well as the skin. In addition, we have shown that immunologic tolerance can be induced by single oral administration of an antigen. The splenocyte cytokine profile study indicated a mixed Th-1, Th-2-type cytokine response in skin-sensitized mice, but a Th-1-type cytokine response in oral mucosa-sensitized mice. By oral tolerance, Th-1 response was inhibited in skin sensitization. On the other hand, by oral tolerance, Th-2-type cytokine response was induced in oral sensitization. These results suggest that skin and oral mucosa sensitization induces different Th-1 and Th-2 balances in excitation and oral tolerance.
